Accretion Pharmaceuticals Limited
ListedSMEHealthcare / Pharma · NSE
Accretion Pharmaceuticals Limited, founded in 2012 and based in Ahmedabad-Sanand, Gujarat, is a pharmaceutical company active in formulations and contract manufacturing with 83 employees as of January 2025. The company offers a wide range of products including tablets, capsules, syrups, ointments, creams, medicated shampoos, dusting powders, and ayurvedic wellness products, and also provides third-party manufacturing services. The proposed fund usage mainly focuses on growth capex such as facility upgrades and new machinery to increase capacity and support exports to 20+ countries, along with working capital needs, limited debt repayment, and flexibility for general purposes, helping the company scale operations, maintain quality standards, improve liquidity, and support future expansion opportunities.
Price Band
₹101
Issue Size
₹29.75 Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹101
at current GMP
Subscribed
7.32x
overall
Open
14 May 2025
Close
16 May 2025
Allotment
19 May 2025
Refund
20 May 2025
Demat Credit
21 May 2025
Listing
21 May 2025
Last updated 12 days ago
Overall Subscription
7.32x
Total Demand
QIB Multiplier
12.14x
Institutions & Funds
NII / HNI
4.41x
High Net-Worth
Retail (RII)
10.55x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 141,600 | 1,719,600 | 12.14x |
| NIB | 1,222,800 | 5,391,600 | 4.41x |
| RETAIL | 1,222,800 | 12,895,200 | 10.55x |
| Total | 2,587,200 | 20,006,400 | 7.32x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 4 | 0.00x |
| NIB | — | 889 | 0.00x |
| RETAIL | — | 10,746 | 0.00x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Accretion Pharmaceuticals Limited Public Issue & Market Profile
Accretion Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare / Pharma sector with an aggregate issue size of ₹29.75 Crores. The shares are offered at a price band of ₹101 to ₹101 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,21,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-05-21, while un-allotted funds or UPI block mandates will be released on 2025-05-20.
Frequently Asked Questions
What is Accretion Pharmaceuticals Limited IPO GMP today?
Currently, Accretion Pharmaceuticals Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹101 to ₹101 per equity share.
What is the expected profit per lot for Accretion Pharmaceuticals Limited IPO?
The retail lot size is 1200 shares requiring a minimum application amount of ₹1,21,200. Expected listing price is ₹101 per equity share.
What is the issue size and price band for Accretion Pharmaceuticals Limited IPO?
The Accretion Pharmaceuticals Limited IPO aggregate issue size is ₹29.75 Crores with an equity price band set at ₹101 to ₹101 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,21,200.
How can I check Accretion Pharmaceuticals Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 7.32x (Retail: 10.55x, QIB: 12.14x, NII: 4.41x). You can track live multiples directly on our dedicated subscription page.
Where and when will Accretion Pharmaceuticals Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-05-19. Investors can verify status using PAN card or application number.
When is the listing date for Accretion Pharmaceuticals Limited IPO?
Accretion Pharmaceuticals Limited shares are scheduled to list on NSE on 2025-05-21.